Archives of Medical Research
Volume 40, Issue 8 , Pages 673-676 , November 2009

What Have We Learned from the Novel Influenza A (H1N1) Pandemic in 2009 for Strengthening Pandemic Influenza Preparedness?

  • José Santos-Preciado

      Affiliations

    • Infectious Diseases and Clinical Immunology Unit, Department of Experimental Medicine, School of Medicine, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico
    • ,
  • Carlos Franco-Paredes

      Affiliations

    • Emory University, Atlanta, Georgia
    • Hospital Infantil de Mexico, Federico Gómez, Mexico City, Mexico
    • Corresponding Author InformationAddress reprint requests to: Carlos Franco-Paredes MD, MPH, Associate Professor of Medicine and Global Health, Emory University, 550 Peachtree Street, Atlanta, GA 30308; Phone; (404) 686-5885; FAX: (404) 686-4508
    • ,
  • Isabel Hernandez-Flores

      Affiliations

    • Universidad de Guanajuato, León, Guanajuato, México
    • ,
  • Ildefonso Tellez

      Affiliations

    • Rollins School of Public Health, Emory University, Atlanta, Georgia
    • ,
  • Carlos Del Rio

      Affiliations

    • Rollins School of Public Health, Emory University, Atlanta, Georgia
    • ,
  • Roberto Tapia-Conyer

      Affiliations

    • Instituto Carso de la Salud, Mexico City, Mexico

Received 22 October 2009 ,Accepted 29 October 2009.

References 

  1. Blaser MJ. Pandemics and preparations. J Infect Dis. 2006;194(suppl 2):S70–S71
  2. Franco-Paredes C, Carrasco P, Santos-Preciado JI. The first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparedness. J Immune Based Ther Vaccines. 2009;7:2
  3. Franco-Paredes C, Carrasco P, Del Rio C, et al. Respuesta en Mexico al actual brote de influenza H1N1. Rev Salud Publ Mex. 2009;51:183–186
  4. Barry JM. The Great Influenza. The Story of the Deadliest Pandemic in History. New York: Penguin Books; 2005;
  5. Lowen AC, Mubareka S, Steel J, et al. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 2007;193:1470–1474
  6. Novel Swine-Origin Influenza A (H1N1). Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–2615
  7. World Health Organization. Influenza A (H1N1)—Update 46. World Health Organization, Geneva, Switzerland. Available at: http://www.who.int/csr/don/2009_06_10a/en/index.html (accessed June 11, 2009).
  8. Fraser C, Donnelly CA, Cauchemez S, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009;324:1557–1561
  9. Taubenberger JK. The virulence of the 1918 pandemic influenza virus: unraveling the enigma. Arch Virol. 2005;(suppl 19):101–115
  10. Fedson DS. Meeting the challenge of influenza pandemic preparedness in developing nation states. Emerg Infect Dis. 2009;15:365–371
  11. Stein RA. Lessons from outbreaks of H1N1 influenza. Ann Intern Med. 2009;151:59–62
  12. Couzin-Frankel J. Swine flu outbreak—What role for antiviral drugs?. Science. 2009;324:705
  13. Franco-Paredes C, Tellez I, Del Rio C, et al. Pandemic influenza: impact of avian influenza. Salud Pub Mex. 2005;2(47):107–109
  14. Kieny MP, Costa A, Carrasco P, et al. A global pandemic influenza vaccine action plan. Vaccine. 2006;24:6367–6370
  15. World Health Organization. Influenza activity in the world—19 October 2009. Available at: http://www.who.int/csr/disease/influenza/update/en/print.html (accessed: October 21, 2009).
  16. World Health Organization. Weekly Update. Pandemic (H1N1) 2009—update 63 (available at: http://www.who.int/csr/don/2009_08_28/en/index.html).
  17. Centers for Disease Control and Prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR. 2009;22:521–524
  18. World Health Organization. WHO strategic actions plan for pandemic influenza. Geneva: World Health Organization; 2007;
  19. Markel H, Lipman HB, Alexander . Nonpharmaceutical interventions implemented by US cities during the 1918–1919 influenza pandemic. JAMA. 2007;298:644–654
  20. Jack A. The problem with flu vaccines. Br Med J. 2009;338:1298–1299
  21. World Health Organization. Draft guidelines for the deployment of a pandemic influenza vaccine. Geneva: WHO; 2008;

 Conflicts of interest: All authors have no conflicts of interest to disclose. All authors reviewed data and final version of the manuscript.

PII: S0188-4409(09)00200-8

doi: 10.1016/j.arcmed.2009.10.011

Archives of Medical Research
Volume 40, Issue 8 , Pages 673-676 , November 2009

Article Tools